Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in mice

Detalhes bibliográficos
Autor(a) principal: Cerqueira, Gilberto Santos
Data de Publicação: 2012
Outros Autores: Santos e Silva, Gabriela dos, Vasconcelos, Emiliano Rios, Fragoso de Freitas, Ana Paula, Moura, Brinell Arcanjo, Macedo, Danielle Silveira, Souto, Augusto Lopes, Barbosa Filho, Jose Maria, Almeida Leal, Luzia Kalyne de, Castro Brito, Gerly Anne de, Souccar, Caden [UNIFESP], Barros Viana, Glauce Socorro de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1016/j.ejphar.2012.02.043
http://repositorio.unifesp.br/handle/11600/34892
Resumo: This study investigates the gastroprotective effects of hecogenin, a steroid saponin isolated from Agave sisalana, on experimental models of gastric ulcer. Male Swiss mice were used in the models of ethanol-and indometacin-induced gastric ulcer. To clarify the hecogenin mechanism of action, the roles of nitric oxide (NO), sulfhydryls (GSH), K-ATP(+) channels and prostaglandins were also investigated, and measurements of lipid peroxidation (TBARS assay) and nitrite levels in the stomach of hecogenin-treated and untreated animals were performed. Furthermore, the effects of hecogenin on myeloperoxidase (MPO) release from human neutrophils were assessed in vitro. Our results showed that hecogenin (3.1, 7.5, 15, 30, 60 and 90 mg/kg, p.o.) acutely administered, before ethanol or indomethacin, exhibited a potent gastroprotective effect. Although the pretreatments with L-NAME, an iNOS inhibitor, and capsazepine, a TRPV1 receptor agonist, were not able to reverse the hecogenin effect, this was reversed by glibenclamide, a K-ATP(+) blocker, and indomethacin in the model of ethanol-induced gastric lesions. the hecogenin pretreatment normalized GSH levels and significantly reduced lipid peroxidation and nitrite levels in the stomach, as evaluated by the ethanol-induced gastric lesion model. the drug alone increased COX-2 expression and this effect was further enhanced in the presence of ethanol. It also decreased MPO release and significantly protected the gastric mucosa. in conclusion, we showed that hecogenin presents a significant gastroprotective effect that seems to be mediated by K-ATP(+) channels opening and the COX-2/PG pathway. in addition, its antioxidant and anti-inflammatory properties may play a role in the gastroprotective drug effect. (C) 2012 Elsevier B. V. All rights reserved.
id UFSP_236e49da24a77b039e4836348239a53d
oai_identifier_str oai:repositorio.unifesp.br/:11600/34892
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in miceAntiulcerogenic activityHecogeninSteroid saponinAgave sisalanaGastroprotection mechanism of actionThis study investigates the gastroprotective effects of hecogenin, a steroid saponin isolated from Agave sisalana, on experimental models of gastric ulcer. Male Swiss mice were used in the models of ethanol-and indometacin-induced gastric ulcer. To clarify the hecogenin mechanism of action, the roles of nitric oxide (NO), sulfhydryls (GSH), K-ATP(+) channels and prostaglandins were also investigated, and measurements of lipid peroxidation (TBARS assay) and nitrite levels in the stomach of hecogenin-treated and untreated animals were performed. Furthermore, the effects of hecogenin on myeloperoxidase (MPO) release from human neutrophils were assessed in vitro. Our results showed that hecogenin (3.1, 7.5, 15, 30, 60 and 90 mg/kg, p.o.) acutely administered, before ethanol or indomethacin, exhibited a potent gastroprotective effect. Although the pretreatments with L-NAME, an iNOS inhibitor, and capsazepine, a TRPV1 receptor agonist, were not able to reverse the hecogenin effect, this was reversed by glibenclamide, a K-ATP(+) blocker, and indomethacin in the model of ethanol-induced gastric lesions. the hecogenin pretreatment normalized GSH levels and significantly reduced lipid peroxidation and nitrite levels in the stomach, as evaluated by the ethanol-induced gastric lesion model. the drug alone increased COX-2 expression and this effect was further enhanced in the presence of ethanol. It also decreased MPO release and significantly protected the gastric mucosa. in conclusion, we showed that hecogenin presents a significant gastroprotective effect that seems to be mediated by K-ATP(+) channels opening and the COX-2/PG pathway. in addition, its antioxidant and anti-inflammatory properties may play a role in the gastroprotective drug effect. (C) 2012 Elsevier B. V. All rights reserved.Univ Fed Ceara, Dept Physiol & Pharmacol, BR-60431270 Fortaleza, Ceara, BrazilUniv Fed Ceara, Dept Pharm, BR-60431270 Fortaleza, Ceara, BrazilUniv Fed Paraiba, Dept Pharmaceut Sci, BR-58100000 Joao Pessoa, Paraiba, BrazilUniv Fed Ceara, Dept Morphol, BR-60431270 Fortaleza, Ceara, BrazilUniversidade Federal de São Paulo, Dept Pharmacol, BR-04044020 São Paulo, BrazilUniversidade Federal de São Paulo, Dept Pharmacol, BR-04044020 São Paulo, BrazilWeb of ScienceConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Elsevier B.V.Univ Fed CearaUniv Fed ParaibaUniversidade Federal de São Paulo (UNIFESP)Cerqueira, Gilberto SantosSantos e Silva, Gabriela dosVasconcelos, Emiliano RiosFragoso de Freitas, Ana PaulaMoura, Brinell ArcanjoMacedo, Danielle SilveiraSouto, Augusto LopesBarbosa Filho, Jose MariaAlmeida Leal, Luzia Kalyne deCastro Brito, Gerly Anne deSouccar, Caden [UNIFESP]Barros Viana, Glauce Socorro de2016-01-24T14:27:14Z2016-01-24T14:27:14Z2012-05-15info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion260-269application/pdfhttp://dx.doi.org/10.1016/j.ejphar.2012.02.043European Journal of Pharmacology. Amsterdam: Elsevier B.V., v. 683, n. 1-3, p. 260-269, 2012.10.1016/j.ejphar.2012.02.043WOS000303436200036.pdf0014-2999http://repositorio.unifesp.br/handle/11600/34892WOS:000303436200036engEuropean Journal of Pharmacologyinfo:eu-repo/semantics/openAccesshttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policyreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-08T12:12:24Zoai:repositorio.unifesp.br/:11600/34892Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-08T12:12:24Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in mice
title Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in mice
spellingShingle Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in mice
Cerqueira, Gilberto Santos
Antiulcerogenic activity
Hecogenin
Steroid saponin
Agave sisalana
Gastroprotection mechanism of action
title_short Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in mice
title_full Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in mice
title_fullStr Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in mice
title_full_unstemmed Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in mice
title_sort Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in mice
author Cerqueira, Gilberto Santos
author_facet Cerqueira, Gilberto Santos
Santos e Silva, Gabriela dos
Vasconcelos, Emiliano Rios
Fragoso de Freitas, Ana Paula
Moura, Brinell Arcanjo
Macedo, Danielle Silveira
Souto, Augusto Lopes
Barbosa Filho, Jose Maria
Almeida Leal, Luzia Kalyne de
Castro Brito, Gerly Anne de
Souccar, Caden [UNIFESP]
Barros Viana, Glauce Socorro de
author_role author
author2 Santos e Silva, Gabriela dos
Vasconcelos, Emiliano Rios
Fragoso de Freitas, Ana Paula
Moura, Brinell Arcanjo
Macedo, Danielle Silveira
Souto, Augusto Lopes
Barbosa Filho, Jose Maria
Almeida Leal, Luzia Kalyne de
Castro Brito, Gerly Anne de
Souccar, Caden [UNIFESP]
Barros Viana, Glauce Socorro de
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Univ Fed Ceara
Univ Fed Paraiba
Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Cerqueira, Gilberto Santos
Santos e Silva, Gabriela dos
Vasconcelos, Emiliano Rios
Fragoso de Freitas, Ana Paula
Moura, Brinell Arcanjo
Macedo, Danielle Silveira
Souto, Augusto Lopes
Barbosa Filho, Jose Maria
Almeida Leal, Luzia Kalyne de
Castro Brito, Gerly Anne de
Souccar, Caden [UNIFESP]
Barros Viana, Glauce Socorro de
dc.subject.por.fl_str_mv Antiulcerogenic activity
Hecogenin
Steroid saponin
Agave sisalana
Gastroprotection mechanism of action
topic Antiulcerogenic activity
Hecogenin
Steroid saponin
Agave sisalana
Gastroprotection mechanism of action
description This study investigates the gastroprotective effects of hecogenin, a steroid saponin isolated from Agave sisalana, on experimental models of gastric ulcer. Male Swiss mice were used in the models of ethanol-and indometacin-induced gastric ulcer. To clarify the hecogenin mechanism of action, the roles of nitric oxide (NO), sulfhydryls (GSH), K-ATP(+) channels and prostaglandins were also investigated, and measurements of lipid peroxidation (TBARS assay) and nitrite levels in the stomach of hecogenin-treated and untreated animals were performed. Furthermore, the effects of hecogenin on myeloperoxidase (MPO) release from human neutrophils were assessed in vitro. Our results showed that hecogenin (3.1, 7.5, 15, 30, 60 and 90 mg/kg, p.o.) acutely administered, before ethanol or indomethacin, exhibited a potent gastroprotective effect. Although the pretreatments with L-NAME, an iNOS inhibitor, and capsazepine, a TRPV1 receptor agonist, were not able to reverse the hecogenin effect, this was reversed by glibenclamide, a K-ATP(+) blocker, and indomethacin in the model of ethanol-induced gastric lesions. the hecogenin pretreatment normalized GSH levels and significantly reduced lipid peroxidation and nitrite levels in the stomach, as evaluated by the ethanol-induced gastric lesion model. the drug alone increased COX-2 expression and this effect was further enhanced in the presence of ethanol. It also decreased MPO release and significantly protected the gastric mucosa. in conclusion, we showed that hecogenin presents a significant gastroprotective effect that seems to be mediated by K-ATP(+) channels opening and the COX-2/PG pathway. in addition, its antioxidant and anti-inflammatory properties may play a role in the gastroprotective drug effect. (C) 2012 Elsevier B. V. All rights reserved.
publishDate 2012
dc.date.none.fl_str_mv 2012-05-15
2016-01-24T14:27:14Z
2016-01-24T14:27:14Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.ejphar.2012.02.043
European Journal of Pharmacology. Amsterdam: Elsevier B.V., v. 683, n. 1-3, p. 260-269, 2012.
10.1016/j.ejphar.2012.02.043
WOS000303436200036.pdf
0014-2999
http://repositorio.unifesp.br/handle/11600/34892
WOS:000303436200036
url http://dx.doi.org/10.1016/j.ejphar.2012.02.043
http://repositorio.unifesp.br/handle/11600/34892
identifier_str_mv European Journal of Pharmacology. Amsterdam: Elsevier B.V., v. 683, n. 1-3, p. 260-269, 2012.
10.1016/j.ejphar.2012.02.043
WOS000303436200036.pdf
0014-2999
WOS:000303436200036
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv European Journal of Pharmacology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
eu_rights_str_mv openAccess
rights_invalid_str_mv http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.format.none.fl_str_mv 260-269
application/pdf
dc.publisher.none.fl_str_mv Elsevier B.V.
publisher.none.fl_str_mv Elsevier B.V.
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268336053157888